Description
Ulfate Oral Suspension is a medication manufactured by Incepta Pharmaceuticals Ltd., containing Sucralfate as its active ingredient. Each 5 ml of the suspension delivers 1 gram of Sucralfate. Sucralfate is a non-systemic agent that works locally in the gastrointestinal tract. It forms a protective barrier over ulcers and erosions in the stomach and duodenum, shielding them from gastric acids, pepsin, and bile salts, thereby promoting healing and reducing discomfort. Ulfate is primarily indicated for the treatment of duodenal ulcers, gastric ulcers, chronic gastritis, and for the prophylaxis of gastrointestinal hemorrhage from stress ulceration in seriously ill patients. The usual adult dosage is 1 gram taken four times daily, one hour before meals and at bedtime. The maximum recommended dose is 8 grams per day. Treatment duration typically ranges from four to six weeks, but may extend up to twelve weeks in resistant cases. It's important to note that Ulfate should be taken on an empty stomach, and antacids should not be administered within 30 minutes before or after taking the medication. Common side effects may include headache, nausea, abdominal pain, constipation, and diarrhea. Caution is advised when using Ulfate in patients with renal dysfunction due to the possibility of increased aluminum absorption. The safety and efficacy of Ulfate in children under 14 years of age have not been established. As with all medications, it's essential to follow the prescribed dosage and consult a healthcare provider for any concerns or side effects
.jpeg)
.jpg)
.png)
.jpg)
.jpg)
.jpeg)
.jpg)
.webp)
.webp)
.jpg)
.webp)
.jpg)
.jpg)
.jpg)
 100 IU 3 ML.webp)
.jpeg)
 400MG.jpg)
.jpeg)
Change Language